It also plans to expand to other states as well Cochin, October 04, 2021:The Hyderabad based 24 years old leading…
Mumbai, June 04, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has…
TECERIS® aimed at expanding access to metastatic breast cancer patients in India Vishakhapatnam, September 29, 2019: Eisai Pharmaceuticals India Pvt.…
Aiming to Expand Availability of Eribulin to Patients in India with Two Brands Halaven and Teceris Tokyo, September 21, 2019: …
Mylan, November 18, 2018: a global pharmaceutical company is hosting the 2018 Mylan Hackathon at its Global Center in Bengaluru on October 13-14,…
Fulphila is expected to be the first biosimilar pegfilgrastim available in the U.S. to help patients with nonmyeloid cancers reduce…
New Delhi, March 29, 2018: Management teams were generally optimistic on the outlook for domestic Indian markets, with sales growth…
SAUGELLA®, with natural plant extracts, is the preferred brand for intimate hygiene among customers in over 30 countries and is the only…